How to Buy Infusystem Holdings Stock
Infusystem Holdings Inc
InfuSystem Holdings, Inc. engages in the provision of health care services. The company is headquartered in Madison Heights, Michigan and currently employs 238 full-time employees.
Infusystem Holdings stock last closed at $4.72, down 4.07% from the previous day, and has decreased 37.15% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.05 percentage points. Infusystem Holdings stock is currently +2.39% from its 52-week low of $4.61, and -52.66% from its 52-week high of $9.97.
There are currently 21.01M shares of INFU outstanding. The market cap of INFU is $99.16M. In the past 24 hours, 171,516 INFU shares were traded.
How to Buy Infusystem Holdings Stock
Not sure how to invest in Infusystem Holdings stock? Here's how.
- Choose where to buy Infusystem Holdings stock: You need to decide on an online brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you determine where to buy Infusystem Holdings stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit money your investment account: Select your payment method and add your info.
- Research Infusystem Holdings stock: The Infusystem Holdings ticker symbol is INFU. Is Infusystem Holdings stock a good investment? Should you buy shares of INFU? How do INFU's underlying business fundamentals look? Do top analysts think Infusystem Holdings is a good buy? Why has INFU's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if INFU is a good stock to buy).
- Make your INFU purchase: Decide if you will purchase INFU shares at the current market price or use a limit order to buy INFU stock at a specific price.
- Get updates on your INFU investment: Create a watchlist to important updates regarding your investment in Infusystem Holdings stock.
Step 1: Choose where to buy Infusystem Holdings stock
You need a brokerage account in order to access the NYSEMKT market and buy INFU shares.
Our preferred brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. eToro gives you:
- Invest in stocks with zero commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Technology to Utilities, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal info so you are able to buy INFU today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start a new brokerage account.
- Submit your info by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've filled out your info on a mobile trading app, your next step is to transfer the money for your investment:
Check out the walkthrough below for more details depositing money into your new investment account.
Step 4: Research Infusystem Holdings stock
Once you have decided on the best place to buy Infusystem Holdings stock, it's critical to evaluate their stock before you buy, so you truly understand the risk as well as the upside.
Infusystem Holdings Metrics
Fundamentals of Infusystem Holdings
WallStreetZen was created to help part-time investors do better fundamental analysis.
You can see all of the due diligence checks on INFU's stock page.
What is the fair value of INFU stock?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge INFU's intrinsic value.
Using relative valuations measures:
- INFU may be overvalued based on its P/E ratio of 42.91x, relative to Medical Instruments & Supplies industry P/E ratio of 40.62x
- INFU could be undervalued based on its P/B ratio of 1.72x, relative to Medical Instruments & Supplies industry P/B ratio of 3.73x
- INFU may be overvalued based on its PEG ratio of 6.22x
You can access additional valuation research on INFU's stock here.
INFU Financial Health Summary
Positive Health Checks:
- Total INFU debt is lower than 5 years ago, relative to shareholder equity.
- INFU profit margin has gone up from 0.7% to 1.7% in the past year.
- INFU's operating cash flow of $20.46M allows it to safely service it's debt of $28.42M.
- There are more short-term assets than long-term liabilities on the INFU balance sheet.
- There are more short-term assets than short-term liabilities on the INFU balance sheet.
Negative Health Checks:
- INFU earnings of $6.84M is not enough to cover its interest payments.
- INFU has a relatively high debt to equity ratio of 0.8.
Metrics for Advanced INFU Traders
INFU Growth Numbers
Last year, INFU earnings were $2.35M. During the past five year, INFU's earnings have grown by 9.46% per year. This was slower than the Medical Instruments & Supplies industry average of 24.59%.
Last year, INFU revenue was $134.86M. Over the past five year, INFU's revenue has grown by 10.7% per year. This was faster than the Medical Instruments & Supplies industry average of 9.67%.
You can research INFU's earnings and revenue performance here.
Are INFU executives and large shareholders buying or selling the stock?
In the last 12 months, insiders at INFU have sold more shares than they have bought.
Richard Dilorio, Chief Executive Officer of INFU, was the latest INFU insider to buy. They bought $65,000.00 worth of INFU stock on Mar 7, 2025.
Learn more about who owns INFU shares here.
Can I rely on INFU as an income stream?
No, Infusystem Holdings doesn't provide an income stream by paying out dividends.
What others are saying about INFU
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your INFU purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly fine. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be sure you're buying or selling at a given dollar amount limit, place a limit order.
Click the Open Trade button and eToro will place the order.
If you want additional help with investing in stocks on eToro, click the how to video below:
Step 6: Get updates on your INFU investment
Now that you own some INFU stock, you'll want to stay up-to-date on your new shares.
Put INFU on a watchlist to get alerted to the latest events about your INFU stock.
INFU Feed
How to Buy Stock in Infusystem Holdings
To summarize, here are the 6 steps to buy stock in Infusystem Holdings:
- Choose where to buy Infusystem Holdings stock
- Sign up for your brokerage account
- Deposit money your investment account
- Research Infusystem Holdings stock
- Make your INFU purchase
- Get updates on your INFU investment
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep tabs on your new investment in Infusystem Holdings, get started below.
Trending Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.